First Surgery with Interwedge Standalone Lateral Implant
Foundation Surgical's Interwedge is designed to provide surgeons with a versatile standalone option for lateral interbody fusion procedures. Sep 09, 2025
NovaBone Debuts Bioactive Pre-contoured Wedge
The Bioactive Pre-contoured Wedge is the first fully-synthetic, porous bioactive glass solution to come to market and is specifically designed with osteostimulation in mind. Sep 09, 2025
University of Utah Unveils Dynamic Compression Implant
The platform technology includes bone screws, intramedullary fixation devices, and hybrid devices that address a broad range of orthopedic surgical indications. Sep 09, 2025
Elute Enters Strategic Partnership with Spartan Medical
This collaboration will expand access of Elute's BonVie+ bone graft substitute to physicians and patients at U.S. VA and DoD medical facilities worldwide. Sep 09, 2025
aap Completes Clinical Trial for Antibacterial Surface Technology
The aim of the human clinical trial is to approve antibacterial plates and screws for the treatment of ankle fractures. Sep 09, 2025
Locate Bio Expands RESTORE Clinical Study to the US
LDGraft is an investigational bone graft substitute that encapsulates, rather than surface attaches, recombinant human Bone Morphogenetic Protein-2. Sep 08, 2025
First US Patient Enrolled in BioPoly Partial Resurfacing Knee Clinical Trial
Instead of replacing the entire joint, BioPoly replaces only the damaged portion, thus preserving the patient’s natural joint tissue. Sep 05, 2025
OrthoPediatrics Enters Distribution Agreement with MY01
This collaboration will expand access to MY01’s Continuous Perfusion Sensing Technology Platform for children and adolescents, a population at great risk for acute compartment syndrome. Sep 05, 2025
Lenoss Medical Expands OsteoPearl Global Patent Protection
OsteoPearl is a biological allograft implant designed to augment osteoporotic vertebral compression fractures by providing a natural scaffold for physiological fracture repair. Sep 05, 2025
Heraeus Medical Acquires Synthecure from Austin Medical Ventures
Synthecure is a 100% synthetic calcium sulfate bone void filler that can be used directly at the site of infection in bone cavities and defects. Sep 04, 2025
